CDC: increase in tianeptine exposures from 2014 to 2017

CDC: increase in tianeptine exposures from 2014 to 2017

(HealthDay)—From 2014 to 2017 there was an increase in tianeptine exposure calls reported by poison control centers to the National Poison Data System, and they mainly occurred among those aged 21 to 40 years, according to research published in the Aug. 3 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Tharwat El Zahran, M.D., from the CDC in Atlanta, and colleagues characterized to tianeptine, an atypical tricyclic drug not approved for medical use in the United States, by analyzing all tianeptine-related exposure calls reported by poison control centers to the National Poison Data System during 2000 to 2017.

The researchers found that during 2014 to 2017 there was an increase in tianeptine exposure calls, including those for intentional abuse or misuse, indicative of a possible emerging . Most of the exposures occurred among those aged 21 to 40 years and had moderate outcomes. The most commonly reported effects were neurologic, cardiovascular, and gastrointestinal signs and symptoms; some effects mimicked opioid toxicity. Clinical effects of withdrawal were also reported in a substantial number of tianeptine exposure calls. There were 83 tianeptine exposures with noted co-exposures, most commonly phenibut, ethanol, benzodiazepines, and opioids.

"The associated outcomes and associated with tianeptine use suggest a possible emerging public health risk and underscore the need for public outreach to increase awareness," the authors write.


Explore further

Michigan approves ban on antidepressant tianeptine sodium

More information: Abstract/Full Text

Copyright © 2018 HealthDay. All rights reserved.

Citation: CDC: increase in tianeptine exposures from 2014 to 2017 (2018, August 17) retrieved 18 July 2019 from https://medicalxpress.com/news/2018-08-cdc-tianeptine-exposures.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more